Loading...
Loading...
JP Morgan initiates Molina Healthcare
MOH with a Neutral rating and a price target of $24.
JP Morgan comments, "While its position as the fifth largest Medicaid player leaves it as one of the more compelling top-line growth stories particularly given its exposure to the near-term Dual Eligible opportunity, Molina's earnings trajectory is much less clear given the headwinds from higher than expected medical costs in Texas and as well as the pace and potential of the earnings contribution from the Duals. Look for key upcoming catalysts to be visible on Texas rates and the imminent Supreme Court decision on healthcare reform."
MOH closed at $22.28 on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in